Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Cytotoxic T cells.

Andersen MH, Schrama D, Thor Straten P, Becker JC.

J Invest Dermatol. 2006 Jan;126(1):32-41. Review.

2.

Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.

Arancia G, Malorni W, Donelli G.

Ann Ist Super Sanita. 1990;26(3-4):369-84. Review.

PMID:
2151107
3.

Molecular mechanisms and biological significance of CTL avidity.

Snyder JT, Alexander-Miller MA, Berzofskyl JA, Belyakov IM.

Curr HIV Res. 2003 Jul;1(3):287-94. Review.

PMID:
15046253
4.

Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.

Kessler B, Hudrisier D, Schroeter M, Tschopp J, Cerottini JC, Luescher IF.

J Immunol. 1998 Dec 15;161(12):6939-46.

5.

Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.

Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, Suga N, Mitsudome A, Zaitsu M, Ishida Y, Shirakata Y, Sayama K, Hashimoto K, Yasukawa M.

J Immunol. 2003 Feb 15;170(4):2205-13.

6.
7.

Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice.

Zhou T, Bluethmann H, Eldridge J, Brockhaus M, Berry K, Mountz JD.

J Immunol. 1991 Jul 15;147(2):466-74.

PMID:
1830064
9.

Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.

de Vries JE, Yssel H, Spits H.

Immunol Rev. 1989 Jun;109:119-41. Review.

PMID:
2527803
10.

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Lowin B, Hahne M, Mattmann C, Tschopp J.

Nature. 1994 Aug 25;370(6491):650-2.

PMID:
7520535
11.

Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.

Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A.

Eur J Immunol. 1992 Aug;22(8):2047-53.

PMID:
1379184
12.
13.

CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.

Altvater B, Pscherer S, Landmeier S, Niggemeier V, Juergens H, Vormoor J, Rossig C.

Clin Exp Immunol. 2006 Jun;144(3):447-57.

14.

Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity.

Esser MT, Krishnamurthy B, Braciale VL.

J Exp Med. 1996 Apr 1;183(4):1697-706.

15.
16.

FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.

Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, Zinkernagel RM.

J Immunol. 2000 Jun 1;164(11):5761-70.

18.

Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.

Nerreter T, Distler E, Köchel C, Einsele H, Herr W, Seggewiss-Bernhardt R.

Exp Hematol. 2013 Jul;41(7):604-614.e4. doi: 10.1016/j.exphem.2013.02.013. Epub 2013 Mar 4.

PMID:
23466625
19.

Cytolytic effector function is present in resting peripheral T lymphocytes.

Geisberg M, Dupont B.

Int Immunol. 1992 Nov;4(11):1273-81.

PMID:
1472478
20.

CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions.

Franciszkiewicz K, Le Floc'h A, Boutet M, Vergnon I, Schmitt A, Mami-Chouaib F.

Cancer Res. 2013 Jan 15;73(2):617-28. doi: 10.1158/0008-5472.CAN-12-2569. Epub 2012 Nov 27.

Supplemental Content

Support Center